WGS
WGS
GeneDx Holdings Corp.OUTPERFORM
Company Information
SectorHealthcare
IndustryMedical - Diagnostics & Research
Market Cap$2.58B
Analysts Rating2.1/5
Recommendation Details
PortfolioSmallcap
DateSep 4, 2026
ForecastQ Daily Probabilities
56.8%
53.1%
42.2%
Smallcap holds up to 12 names drawn from Small caps above $200M at $1+ share price. Small caps at or above their analyst target across a 12-slot book. No maximum hold, each position carries a 25% stop-loss. Benchmark: Russell 2000.
Company Description
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.